DCTH · Delcath Systems, Inc. · Executive Compensation
Market Cap
$552.06M
Shares
34.70M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $5,765,258 |
| Vojislav Vukovic | Chief Medical Officer | $2,055,395 |
| Martha Rook | Chief Operating Officer | $2,024,228 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $2,157,414 |
| Vojislav Vukovic | Chief Medical Officer | $1,085,612 |
| Martha Rook | Chief Operating Officer | $933,097 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $2,520,314 |
| John Purpura | M.S. Chief Operating Officer | $1,203,027 |
| Kevin Muir | — | $1,015,984 |
| Vojislav Vukovic | Chief Medical Officer | — |
| Martha Rook | Chief Operating Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $1,472,198 |
| John Purpura | M.S. Chief Operating Officer | $804,328 |
| Johnny John | Senior Vice President, Clinical Development and Medical Affairs | $737,504 |
| General Manager | Interventional Oncology | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $1,914,402 |
| John Purpura | Chief Operating Officer | $925,489 |
| Johnny John | Senior Vice President, Clinical Development and Medical Affairs | $875,777 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $5,761,000 |
| John Purpura | Chief Operating Officer | $2,419,270 |
| Johnny John | M.D., Senior Vice President Clinical Development and Medical Affairs | $1,129,767 |
| Christine Padula | Interim Principal Accounting Officer | $426,770 |
| Jennifer K. Simpson | former President/CEO | $253,322 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jennifer K. Simpson | former President/CEO | $1,065,795 |
| Barbra Keck | M.B.A. Former Chief Financial Officer | $700,239 |
| John Purpura | Chief Operating Officer | $682,541 |
| Gerard Michel | Chief Executive Officer | — |
| Christine Padula | Interim Principal Accounting Officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jennifer K. Simpson | Former President and Chief Executive Officer | $541,594 |
| John Purpura | M.S., Chief Operating Officer | $385,000 |
| Barbra Keck | M.B.A. Former Chief Financial Officer | $374,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John R. Sylvester | Class II director | Appointed | 2026-05-14 |
| Elizabeth Czerepak | Class II director | Appointed | 2026-05-14 |
| Gilad Aharon | Class I director | Appointed | 2025-05-16 |
| Gerard Michel | Class I director | Appointed | 2025-05-16 |
Key facts
CIK
872912
CUSIP
24661P807
13F (30d)
65 filings
65 filers
Visit website
Investor relations